Detail akcie DOTTIKON ES HLDG Rg online

Business Summary: Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2026, Dottikon ES Holding AG revenues increased 11% to SF428.4M. Net income decreased 2% to SF103.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by The Pharmaceutical segment income decrease of 1% to SF116.8M. Basic Earnings per Share excluding Extraordinary Items decreased from SF7.64 to SF7.49.